港股異動 | 微盟集團(02013.HK)大漲逾8%破頂 獲機構持續唱好
格隆匯1月4日丨微盟集團(02013.HK)延續強勢行情,現漲幅擴大至8.61%,盤中高見15.18港元創歷史新高價,近一個月累計升幅近50%。暫成交5.27億港元,總市值達341億港元。西部證券日前稱,公司作為電商SaaS產業領域龍頭,經營情況較好,維持“買入”評級。微盟順應視頻化趨勢以及積極開拓線下業務促進SaaS業務發展;微信規範廣吿業務體系,微盟精準營銷業務深綁騰訊廣吿會進一步受益。另外,微盟去年11月收購海鼎,全面佈局零售業務。東方證券指出,近年以來微盟投資/併購了多個零售/餐飲SaaS服務商,預計在產品和客户拓展方面的能力進一步加強。予目標價18.06港元及“買入評級”。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.